| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 03/24/1993 | EP0532718A1 ?99m Tc LABELED LIPOSOMES |
| 03/24/1993 | EP0532566A1 ?99m Tc CYCLOPENTADIENYL CARBONYL COMPLEXES, METHOD OF PREPARING THEM, AND THEIR USE IN MEDICAL DIAGNOSIS. |
| 03/23/1993 | US5196577 Radioactive |
| 03/23/1993 | US5196576 Chelating compounds and their use |
| 03/23/1993 | US5196515 Thiolactone bifunctional chelating agents for diagnostic and therapeutic products |
| 03/23/1993 | US5196510 Polypeptides |
| 03/23/1993 | US5196404 Inhibitors of thrombin |
| 03/18/1993 | WO1993004702A1 Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins |
| 03/18/1993 | WO1993002652A3 Modified haptens useful as imaging and therapeutic agents |
| 03/17/1993 | EP0531472A1 Humanized and chimeric monoclonal antibodies |
| 03/16/1993 | US5194594 Conjugation With Heterobifunctional Reagent, Radionucleotide Label |
| 03/16/1993 | US5194581 Biodegradable poly(phosphoesters) |
| 03/16/1993 | US5194425 Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 03/16/1993 | CA1314503C Detectable molecules, method of preparation and use |
| 03/13/1993 | CA2309400A1 Intravascular system with inflatable member and member mounted thereon |
| 03/10/1993 | EP0417191B1 Formulation for antibody reagents |
| 03/10/1993 | EP0406363B1 Method to diagnose amyloidoses specifically and substance therefor |
| 03/09/1993 | US5192526 Kit for preparation of rhenium therapeutic agents for bone cancer without purification |
| 03/09/1993 | US5192525 High affinity tamoxifen derivatives and uses thereof |
| 03/09/1993 | CA1314209C Composition and method for use for liposome encapsulated compounds for neutron capture tumor therapy |
| 03/04/1993 | WO1993004194A1 LABELLED β-AMYLOID PEPTIDE AND ALZHEIMER'S DISEASE DETECTION |
| 03/04/1993 | WO1993003772A1 Imaging of infections |
| 03/03/1993 | EP0529645A1 Process for the preparation of backbone polysubstituted chelates. |
| 03/03/1993 | EP0529031A1 Improved inhibitors of thrombin |
| 03/03/1993 | EP0528891A1 Method for increasing blood-brain barrier permeability |
| 03/02/1993 | US5190742 Device and method for carrying out a plurality of sequential transformations of a substrate |
| 03/02/1993 | US5190741 Aminopropyl Radioactive Iodobenzamides |
| 02/25/1993 | DE4128181A1 New complexes of radioactive technetium - with aldoxime-substd. poly:ol or sugar deriv., useful for imaging the heart, brain and kidneys and for diagnosis of tumours |
| 02/24/1993 | EP0528663A2 Monoclonal antibody to a synaptophysin |
| 02/24/1993 | EP0528007A1 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF $g(b) CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/24/1993 | EP0527954A1 Molecular recognition units |
| 02/24/1993 | EP0527755A1 Improved method for radiolabeling monovalent antibody fragments |
| 02/24/1993 | EP0510132A4 Polymeric carriers for release of covalently linked agents |
| 02/24/1993 | CN1069339A Electrolytic cell and process for labeling of proteins and peptides |
| 02/23/1993 | US5188816 Using polyazamacrocyclic compounds for intracellular measurement of metal ions using MRS |
| 02/18/1993 | WO1993003351A1 Amino acid, ester and/or catechol contrast agents for mri |
| 02/18/1993 | WO1993002708A1 Novel reagent for tumour imaging and therapy |
| 02/18/1993 | WO1993002652A2 Modified haptens useful as imaging and therapeutic agents |
| 02/18/1993 | CA2115275A1 Amino acid, ester and/or catechol contrast agents for mri |
| 02/17/1993 | EP0527131A1 Chelants |
| 02/17/1993 | CN1069027A Aminocarboxylate ligands having substituted aromatic amide moieties |
| 02/16/1993 | US5187264 Technetium chelates to be used for determining the renal function |
| 02/16/1993 | US5187154 Administering cholecystokinins |
| 02/16/1993 | US5187153 Methods of treatment using Alzheimer's amyloid polypeptide derivatives |
| 02/16/1993 | US5186923 Enhancement of cellular accumulation of lipophilic cationic organometallic compounds by reduction of intramembrane potential |
| 02/16/1993 | US5186921 3-methoxy-n(1-ethyl-2-pyrrolidinyl)methyl)naphthyl-2-carboxy amide compounds for imaging human brains; good retention stability |
| 02/16/1993 | US5186913 Tungsten-188/carrier-free rhenium-188 perrhenic acid generator system |
| 02/10/1993 | EP0527056A1 Novel reagent for tumour imaging and therapy |
| 02/10/1993 | EP0403524B1 Preparation of nitruro compounds usable as radio-pharmaceutical products |
| 02/10/1993 | CN1068744A Asialoglycoprotein-conjugated medicinal agent |
| 02/09/1993 | US5185368 Complex with trivalent metal ions; medical diagnosis and therapy |
| 02/09/1993 | US5185142 Antigen-specific composition and in vivo methods for detecting and localizing an antigenic site and for radiotherapy |
| 02/04/1993 | WO1993002105A1 Trifunctional compounds having specificity for multi-drug resistant cells |
| 02/04/1993 | WO1993002045A1 Hydroxamate and hydrazide derivatives of polyamines and their medical use as chelating agents |
| 02/04/1993 | WO1993000064A3 Evaluation and treatment of the multidrug resistance phenotype |
| 02/04/1993 | WO1992019213A3 Enhancement of abnormal tissue uptake of antibodies, tumor-specific agents or conjugates thereof for diagnostic imaging or therapy |
| 02/04/1993 | WO1992013950A3 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/04/1993 | CA2113578A1 Trifunctional compounds having specificity for multi-drug resistant cells |
| 02/02/1993 | US5183653 Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds |
| 02/02/1993 | CA2074867A1 Aminocarboxylate ligands having substituted aromatic amide moieties |
| 01/27/1993 | EP0524722A1 Thiol-reactive maleimido-based radiolabeling reagents |
| 01/27/1993 | EP0524639A2 Process for the labelling of substances with technetium or rhenium |
| 01/26/1993 | US5182107 Delivering nerve growth factor across blood brain barrier to brain |
| 01/23/1993 | WO1993001839A1 Radiopharmaceutical product having in particular a cerebral tropism comprising a transition metal nitride complex, and preparation method therefor |
| 01/23/1993 | CA2113830A1 Radiopharmaceutical product having in particular a cerebral tropism comprising a transition metal nitride complex, and preparation method therefor |
| 01/21/1993 | WO1993001303A1 Tumor, carbohydrate antigen specific monoclonal antibody and cell line |
| 01/21/1993 | WO1993001302A1 Tumor, carbohydrate antigen specific monoclonal antibody and cell line |
| 01/21/1993 | WO1993000934A1 Tissue specific imaging agents using internal image anti-idiotypic antibodies |
| 01/21/1993 | WO1993000927A1 Cancer treatment |
| 01/21/1993 | WO1993000908A1 Elam-1 receptor ligands as diagnostic compounds |
| 01/21/1993 | DE4124121A1 Small-particle grading system - suspends and filters in successive phases causing swelling and shrinkage |
| 01/21/1993 | CA2110819A1 Tissue specific imaging agents using internal image anti-idiotypic antibodies |
| 01/14/1993 | DE4128183C1 New technetium complexes and corresp. complexing agents - useful for measurement of cerebral perfusion, diagnosis of Alzheimer's disease or epilepsy and localisation of tumours |
| 01/13/1993 | EP0522007A1 A fonctionalized complexand |
| 01/13/1993 | EP0521954A1 Technecium complexes of thioethers. |
| 01/07/1993 | WO1993000443A1 Purification of recombinant apolipoprotein e from bacteria |
| 01/07/1993 | WO1993000064A2 Evaluation and treatment of the multidrug resistance phenotype |
| 01/07/1993 | WO1992019573A3 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical |
| 01/07/1993 | WO1992019210A3 Serotinin reuptake inhibitors for s.p.e.c.t imaging |
| 01/07/1993 | EP0521842A2 Tumor antigen specific antibody |
| 01/05/1993 | US5177192 Method for labeling antibodies with a metal ion |
| 01/05/1993 | US5176617 Use of a stent with the capability to inhibit malignant growth in a vessel such as a biliary duct |
| 12/29/1992 | US5175343 For detection, radiotherapy and radeoimaging of tumors |
| 12/29/1992 | US5175269 Compound and detectable molecules having an oligo- or polynucleotide with modifiable reactive group |
| 12/29/1992 | US5175257 Useful for delivering radioisotopes to desired target sites in vivo |
| 12/29/1992 | US5175256 Protein labeling reagents |
| 12/23/1992 | WO1992022583A2 Tri- and tetra-valent monospecific antigen-binding proteins |
| 12/23/1992 | WO1992022334A1 Platelet receptor antagonists useful in detecting intravascular platelet aggregation |
| 12/23/1992 | EP0518982A1 Method for enhancing antibody transport through capillary barriers |
| 12/22/1992 | CA1311700C Production and characteristics of anti-myosin mouse monoclonal antibody |
| 12/20/1992 | WO1992022310A1 Asialoglycoprotein-conjugated medicinal agent |
| 12/20/1992 | CA2089881A1 Asialoglycoprotein-conjugated medicinal agent |
| 12/16/1992 | EP0517754A1 Antibody constructs with enhanced binding affinity |
| 12/15/1992 | US5171755 Containing water insoluble oil, surfactant; red blood cell substitutes, treating cardiovascular disorders |
| 12/15/1992 | US5171749 Wavelength-specific cytotoxic agents |
| 12/15/1992 | US5171665 Monoclonal antibody to novel antigen associated with human tumors |
| 12/15/1992 | US5171563 Cleavable linkers for the reduction of non-target organ retention of immunoconjugates |
| 12/10/1992 | WO1992021379A1 Radiolabeled metal-binding protein for the treatment of arthritis |
| 12/09/1992 | EP0516873A1 A method and kit for protein labelling with 99 mTC |
| 12/08/1992 | US5169933 Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |